Volume 90 Issue 7 | p. 21 | Concentrates
Issue Date: February 13, 2012

Shanghai Pharma Acquires API Maker

Department: Business
Keywords: nucleoside, losartan, Changzhou

Shanghai Pharmaceuticals has offered to acquire a majority stake, later to be followed by 100% ownership, in Changzhou Kony Pharma, a manufacturer of active pharmaceutical ingredients (APIs). Shanghai Pharmaceuticals’ offer values Kony at $48 million. Established in 1986 in Changzhou, Jiangsu province, Kony specializes in nucleoside antiviral APIs and losartan, a blood pressure drug that lost patent protection in 2009. Shanghai Pharmaceuticals says the Changzhou site will complement other API facilities it is building in Shanghai’s Xinghuo development zone.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment